Study of Imatinib in Children With Neurofibromatosis and Airway Tumors

ClinicalTrials.gov ID: NCT03688568

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03688568. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 11, 2026, 10:03 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2 Study of Imatinib in Children With Neurofibromatosis and Airway Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to look at a subset of plexiform neurofibromas and determine if the airway tumors are more sensitive to imatinib therapy. Funding Source - FDA OOPD

Study identification

NCT ID: NCT03688568
Recruitment status: Withdrawn
Study type: Interventional
Phase: Phase 2
Lead sponsor: Indiana University; Other
Enrollment: Not listed

Conditions and interventions

Conditions

Neurofibroma, Plexiform

Interventions

Imatinib Mesylate Drug

Drug

Eligibility (public fields only)

Age range: 6 Months to 12 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 1, 2018 (Actual)
Primary completion: Sep 1, 2020 (Actual)
Completion: Sep 1, 2021 (Estimated)
Last update posted: Feb 12, 2021

2018 – 2021

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Riley Hospital for Children - Indiana University	Indianapolis	Indiana	46202	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03688568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 12, 2021 · Synced Nov 11, 2026